Search Results

Filter
  • 1-10 of  153,137 results for ""Immune Evasion""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.

  • Authors : Li C; Skin Disease Research Institute, The 2nd Hospital and School of Medicine, Zhejiang University, Hangzhou, 310058, China.; Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Hangzhou, 310053, China.

Subjects: Enhancer of Zeste Homolog 2 Protein*/Enhancer of Zeste Homolog 2 Protein*/Enhancer of Zeste Homolog 2 Protein*/genetics ; Enhancer of Zeste Homolog 2 Protein*/Enhancer of Zeste Homolog 2 Protein*/Enhancer of Zeste Homolog 2 Protein*/metabolism ; Immune Evasion*/Immune Evasion*/Immune Evasion*/genetics

  • Source: Nature communications [Nat Commun] 2024 Mar 09; Vol. 15 (1), pp. 2163. Date of Electronic Publication: 2024 Mar 09.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Strategies for Overcoming Immune Evasion in Bladder Cancer.

  • Authors : Shin J; Department of Health Sciences, The Graduate School of Dong-A University, Busan 49315, Republic of Korea.; Park JW

Subjects: Immune Evasion* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology; Humans

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 07; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

SOX17 enables immune evasion of early colorectal adenomas and cancers.

  • Authors : Goto N; Department of Biology, The David H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA, USA.; Westcott PMK

Subjects: Adenoma*/Adenoma*/Adenoma*/immunology ; Adenoma*/Adenoma*/Adenoma*/pathology ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/immunology

  • Source: Nature [Nature] 2024 Mar; Vol. 627 (8004), pp. 636-645. Date of Electronic Publication: 2024 Feb 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A thicker skin for better immune evasion.

  • Authors : Schmidt EN; Deparment of Chemistry, University of Alberta, Edmonton, Alberta, Canada.; Macauley MS

Subjects: Immune Evasion*

  • Source: Nature materials [Nat Mater] 2024 Mar; Vol. 23 (3), pp. 312-313.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101155473 Publication Model: Print Cited Medium: Internet ISSN: 1476-4660

Record details

×
Academic Journal

Uncovering mechanisms underlying complement-mediated cancer immune evasion.

  • Authors : O'Connell P; Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Genetics and Genomic Sciences, The Mount Sinai Hospital, New York, NY, USA

Subjects: Immune Evasion* ; Neoplasms*/Neoplasms*/Neoplasms*/genetics; Humans

  • Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Feb 07; Vol. 32 (2), pp. 277-278. Date of Electronic Publication: 2024 Jan 20.Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.

  • Authors : Qu P; Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210, USA; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA.

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19 Vaccines* ; Immune Evasion* SARS-CoV-2 variants

  • Source: Cell [Cell] 2024 Feb 01; Vol. 187 (3), pp. 585-595.e6. Date of Electronic Publication: 2024 Jan 08.Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

PD-1H/VISTA mediates immune evasion in acute myeloid leukemia.

  • Authors : Kim TK; Division of Hematology/Oncology, Department of Medicine.; Vanderbilt Center for Immunobiology, and.

Subjects: Immune Evasion* ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy; Animals

  • Source: The Journal of clinical investigation [J Clin Invest] 2024 Feb 01; Vol. 134 (3). Date of Electronic Publication: 2024 Feb 01.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

EMT-induced immune evasion: connecting the dots from mechanisms to therapy.

  • Authors : Imodoye SO; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA. .; Adedokun KA

Subjects: Immune Evasion* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Humans

  • Source: Clinical and experimental medicine [Clin Exp Med] 2023 Dec; Vol. 23 (8), pp. 4265-4287. Date of Electronic Publication: 2023 Nov 15.Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Editorial: Antiviral innate immune sensing, regulation, and viral immune evasion.

  • Authors : Lu W; Department of Surgery and Immunobiology and Transplant Science Center, Houston Methodist Research Institute, Houston Methodist, Houston, TX, United States.; Wang L

Subjects: Immune Evasion* ; Immunity, Innate*; Host-Pathogen Interactions

  • Source: Frontiers in immunology [Front Immunol] 2024 Jan 04; Vol. 14, pp. 1358542. Date of Electronic Publication: 2024 Jan 04 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.

  • Authors : Wu H; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital, Jiangxi Medical college, Nanchang University, Nanchang, Jiangxi, China.; Department of Otolaryngology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Subjects: Immune Evasion* ; Head and Neck Neoplasms*; Humans

  • Source: Frontiers in immunology [Front Immunol] 2024 Jan 03; Vol. 14, pp. 1290839. Date of Electronic Publication: 2024 Jan 03 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  153,137 results for ""Immune Evasion""